» Articles » PMID: 20404838

Complement and the Central Nervous System: Emerging Roles in Development, Protection and Regeneration

Overview
Publisher Wiley
Date 2010 Apr 21
PMID 20404838
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

As expanding research reveals the novel ability of complement proteins to promote proliferation and regeneration of tissues throughout the body, the concept of the complement cascade as an innate immune effector has changed rapidly. In particular, its interactions with the central nervous system have provided a wealth of information regarding the ability of complement proteins to mediate neurogenesis, synaptogenesis, cell migration, neuroprotection, proliferation and regeneration. At numerous phases of the neuronal and glial cell cycle, complement proteins exert direct or indirect influence over their behavior and fate. Neuronal stem cells differentiate and migrate in response to complement, and it prevents injury and death in adult cells in response to toxic agents. Furthermore, complement proteins promote survival via anti-apoptotic actions, and can facilitate clearance and regeneration of injured tissues in various models of CNS disease. In summary, we highlight the protean abilities of complement proteins in the central nervous system, underscoring an exciting avenue of research that has yielded greater understanding of complement's role in central nervous system health and disease.

Citing Articles

Standard operating procedure combined with comprehensive quality control system for multiple LC-MS platforms urinary proteomics.

Liu X, Sun H, Hou X, Sun J, Tang M, Zhang Y Nat Commun. 2025; 16(1):1051.

PMID: 39865094 PMC: 11770173. DOI: 10.1038/s41467-025-56337-4.


Acute and chronic blood serum proteome changes in patients with methanol poisoning.

Cejnar P, Smirnova T, Kuckova S, Prochazka A, Zak I, Harant K Sci Rep. 2022; 12(1):21379.

PMID: 36494437 PMC: 9734099. DOI: 10.1038/s41598-022-25492-9.


Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.

van der Ende E, Heller C, Sogorb-Esteve A, Swift I, McFall D, Peakman G J Neuroinflammation. 2022; 19(1):217.

PMID: 36064709 PMC: 9446850. DOI: 10.1186/s12974-022-02573-0.


A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.

van der Ende E, Bron E, Poos J, Jiskoot L, Panman J, Papma J Brain. 2021; 145(5):1805-1817.

PMID: 34633446 PMC: 9166533. DOI: 10.1093/brain/awab382.


Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders.

Zengeler K, Lukens J Nat Rev Immunol. 2021; 21(7):454-468.

PMID: 33479477 PMC: 9213174. DOI: 10.1038/s41577-020-00487-7.